From the Hoos article:
"Time is a luxury GSK can't afford right now."
That goes for all big pharmas. They need to stay ahead in the game. That's why I think vla will be eaten (or in a deal) within months.
As for imu, it's amazing that they have Hoos on-board (or is imu Hoos baby?).